The effect of flurbiprofen 0.03% eye drops on the blood aqueous barrier in extracapsular cataract extraction with IOL implantation.
Preoperative and postoperative anterior chamber fluorophotometry were performed after intravenous administration of fluorescein sodium in patients undergoing extracapsular extraction and posterior chamber lens implantation. The topical application of aqueous flurbiprofen sodium 0.03% solution before and after surgery significantly decreased the surgery mediated disturbance of the blood aqueous barrier as compared to vehicle application (placebo controlled). In contrast to similar studies, cortical steroids were not given topically or systemically to either group of patients during the study. The present fluorophotometric results correlate well with slitlamp biomicroscopy of postoperative inflammation. The data of this study indicate that flurbiprofen ophthalmic solution is effective in protecting the blood aqueous barrier (BAB) in human eyes during cataract surgery and IOL implantation.
Diestelhorst
M
M
University Eye Hospital Cologne, FRG.
Aspacher
F
F
Konen
W
W
Krieglstein
G K
GK
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000867:Anterior Chamber / Q000378:metabolism; D001082:Aqueous Humor / Q000378:metabolism*; D001813:Blood-Retinal Barrier; D002387:Cataract Extraction; D004311:Double-Blind Method; D005480:Flurbiprofen / Q000493:pharmacokinetics*; D006801:Humans; D007910:Lenses, Intraocular; D008875:Middle Aged; D011897:Random Allocation
D005480:Flurbiprofen